OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity. - Wikidata - wikimedia - TriplyDB

OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.

OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.

http://www.wikidata.org/entity/Q34477650

about

CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas Treg functional stability and its responsiveness to the microenvironment Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment.Inherited variants in regulatory T cell genes and outcome of ovarian cancer.Agonist antibodies to TNFR molecules that costimulate T and NK cells Harnessing regulatory T cells to suppress asthma: from potential to therapy.CD4+ regulatory T cells in solid organ transplantation.Targeting regulatory T cells.Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer.Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities.Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.Influence of tumors on protective anti-tumor immunity and the effects of irradiation.Study on the expression of co-stimulatory marker CD134 on CD4+ T cells in HIV-1-infected individuals.Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.Constitutive expression of NF-κB inducing kinase in regulatory T cells impairs suppressive function and promotes instability and pro-inflammatory cytokine production.Eradication of spontaneous malignancy by local immunotherapy.Human Endothelial Cells Modulate CD4+ T Cell Populations and Enhance Regulatory T Cell Suppressive Capacity.Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth

P2860

Q26740520-43593175-B0C7-4A26-9628-E914C566FA7A Q27008946-80F73441-5CFA-4ECD-85F7-F21E65B3A941 Q28730751-2AF51337-9482-49AC-BEA9-4213DBB1FD15 Q33736218-2F58FA6E-1964-46EF-856E-B4EF91ACC497 Q34575290-9364DF33-DDCA-44EB-9B26-FBF5A2DB3433 Q35427446-CDC7BEB3-BBB8-47B0-ADD8-402EEC83E9E6 Q37680540-F0BEF50E-F073-4B27-B931-3560DCF8EBA8 Q37794623-D015007F-AD61-42DC-A7DD-14CA213A428E Q37983467-5BDFA655-E926-41B5-B877-245F8D48CD8C Q38120535-0CD93844-AB85-4B7E-AA32-AEF0236819BF Q38162129-02592248-2AE0-4B9C-9D0A-C00D71C49A0A Q38770814-566DEA65-560E-4884-843A-E828F1D974C5 Q38779877-5AA7EC47-DE7F-47BD-9D16-944A309C4BD2 Q42945799-E302DDAA-30AB-4742-98CF-A28138954AFA Q44948990-10E3FBF5-838D-40A2-BF77-104DE1A32BE5 Q45975829-DD91AC5E-4A5A-499E-BBA6-7021D6FD075A Q47094157-0DF288DB-517F-4939-9D55-B6CB049BAA32 Q48131172-2868F2BB-D286-4625-A7F6-483D50E88699 Q52599680-61723515-76E9-4F4B-884E-F41CE6438F95 Q53078816-81C5E508-B9F2-4A0C-97B2-4B355F6EEC4E Q56898695-C0776A90-494F-4BCE-A48C-DB3D2D34CDDF

P2860

OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.

http://www.wikidata.org/entity/Q34477650

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@ast

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@en

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@nl

type

label

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@ast

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@en

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@nl

prefLabel

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@ast

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@en

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@nl

P1433

Q34477650-2183C421-3606-4FD8-8383-CF0FEA366F54

P1476

Q34477650-A954C71C-0CCB-4658-B4E3-01E396A75445

P2093

Q34477650-02B521FB-4053-41DD-BC4C-9D53B3552D75

Q34477650-0B0A3221-B373-4EC9-8A5B-71F32461159B

Q34477650-145B86AA-B07F-4EFA-9D1A-9518DFE10AC4

Q34477650-3D74ED21-4CA0-4D93-BC03-F13DAD780A73

Q34477650-6F1423E5-3C70-4F73-A6CB-1AFD7375152C

Q34477650-F075180D-C904-47AE-8FC7-951067100DA1

P2860

Q34477650-0BE80201-3FBB-42C8-908C-247B67C730E3

Q34477650-0D879A5B-85AC-4911-9514-B32B1B3199E5

Q34477650-175AD419-C840-4712-879A-04543548426A

Q34477650-20C625B6-6279-4885-B941-5927904EA84D

Q34477650-22CA1A77-0DF0-4C6A-9351-2E2A7C42BFA9

Q34477650-34A09FF3-6E6A-46F1-89A3-D57A48E05D18

Q34477650-35277A62-CC00-4B0A-99B2-200E326918C5

Q34477650-38C886FF-74F0-4E3B-A30A-29D58A842293

Q34477650-39D3C7BD-BB11-419B-8A6A-A27F9C4F220D

Q34477650-49241E31-F5F3-48AE-A0D2-950E47A385BD

P304

Q34477650-F93014DE-FF79-4E93-937B-26BBA1BAAC6B

P31

Q34477650-F81AFDD1-01B8-4553-AB46-D3F098D5D478

P356

Q34477650-06F85E6B-D73A-4039-9809-D36806FAC1FB

P433

Q34477650-9B4A1714-588C-4740-9DA4-456399679A09

P478

Q34477650-9757AEBD-CDBE-4E23-B9E5-F19CECFAE9EC

P50

Q34477650-CE27A76B-95A9-4914-8902-4F084B05F8B2

P577

Q34477650-12556BCA-BEA2-4592-8C78-1DB01E623847

P5875

Q34477650-395996EA-0C29-4B8C-A57C-43B1D4B34168

P698

Q34477650-98FCBF78-A3FC-47BB-9D8B-8626D5CDA7C6

P932

Q34477650-7AD8F4AE-1CB4-4BFA-9556-8D1805812091

P356

P1433

International Journal of Cancer

P1476

OX40 costimulation can abrogat ...... ression of antitumor immunity.

@en

P2093

Eiji Mekata

http://www.w3.org/2001/XMLSchema#string

Naomi Kitamura

http://www.w3.org/2001/XMLSchema#string

R Todd Reilly

http://www.w3.org/2001/XMLSchema#string

Satoshi Murata

http://www.w3.org/2001/XMLSchema#string

Tohru Tani

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Ueki

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells

The costimulation-regulated duration of PKB activation controls T cell longevity

Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

Robust B cell immunity but impaired T cell proliferation in the absence of CD134 (OX40)

P304

630-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.24435

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth Jaffee

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24440267

http://www.w3.org/2001/XMLSchema#string

P698

19455675

http://www.w3.org/2001/XMLSchema#string

P932

3018329

http://www.w3.org/2001/XMLSchema#string